MOH — authorised 28 May 2021
- Marketing authorisation holder: ALKERMES INC
- Status: likely_approved
MOH authorised Lybalvi on 28 May 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 28 May 2021.
ALKERMES INC holds the UAE marketing authorisation.